133 related articles for article (PubMed ID: 26497012)
21. Mutations of the cell cycle regulatory genes p16INK4A and p21WAF1 and the metastasis-inducing gene S100A4 are infrequent and unrelated to p53 tumour suppressor gene status and data on survival in oropharyngeal squamous cell carcinomas.
Ibrahim SO; Lillehaug JR; Vasstrand EN
Anticancer Res; 2003; 23(6C):4593-600. PubMed ID: 14981901
[TBL] [Abstract][Full Text] [Related]
22. Small interfering RNA-directed knockdown of S100A4 decreases proliferation and invasiveness of osteosarcoma cells.
Ma X; Yang Y; Wang Y; An G; Lv G
Cancer Lett; 2010 Dec; 299(2):171-81. PubMed ID: 20855150
[TBL] [Abstract][Full Text] [Related]
23. Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres.
Ji Q; Hao X; Meng Y; Zhang M; Desano J; Fan D; Xu L
BMC Cancer; 2008 Sep; 8():266. PubMed ID: 18803879
[TBL] [Abstract][Full Text] [Related]
24. [Activator of metastasis in cancer cells, Mst1/S100A4 protein binds to tumor suppressor protein p53].
Grigorian M; Lukanidin E
Genetika; 2003 Jul; 39(7):900-8. PubMed ID: 12942774
[TBL] [Abstract][Full Text] [Related]
25. Suppression of inhibitor of differentiation 2, a target of mutant p53, is required for gain-of-function mutations.
Yan W; Liu G; Scoumanne A; Chen X
Cancer Res; 2008 Aug; 68(16):6789-96. PubMed ID: 18701504
[TBL] [Abstract][Full Text] [Related]
26. RNA interference targeting inhibition of S100A4 suppresses cell growth and promotes apoptosis in human laryngeal carcinoma Hep‑2 cells.
Liu J; Fu S; Xu Y; Zheng Z
Mol Med Rep; 2014 Sep; 10(3):1389-94. PubMed ID: 24969174
[TBL] [Abstract][Full Text] [Related]
27. Differential expression of S100A2 and S100A4 in lung adenocarcinomas: clinicopathological significance, relationship to p53 and identification of their target genes.
Matsubara D; Niki T; Ishikawa S; Goto A; Ohara E; Yokomizo T; Heizmann CW; Aburatani H; Moriyama S; Moriyama H; Nishimura Y; Funata N; Fukayama M
Cancer Sci; 2005 Dec; 96(12):844-57. PubMed ID: 16367903
[TBL] [Abstract][Full Text] [Related]
28. Metastasis-associated protein S100A4 and p53 predict relapse in curatively resected stage III and IV (M0) gastric cancer.
Kim YJ; Kim MA; Im SA; Kim TM; Kim DW; Yang HK; Heo DS; Lee KU; Choe KJ; Kim NK; Kim TY; Kim WH; Bang YJ
Cancer Invest; 2008 Mar; 26(2):152-8. PubMed ID: 18259945
[TBL] [Abstract][Full Text] [Related]
29. Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer.
Sack U; Walther W; Scudiero D; Selby M; Kobelt D; Lemm M; Fichtner I; Schlag PM; Shoemaker RH; Stein U
J Natl Cancer Inst; 2011 Jul; 103(13):1018-36. PubMed ID: 21685359
[TBL] [Abstract][Full Text] [Related]
30. S100 calcium-binding protein A4 is a novel independent prognostic factor for the poor prognosis of gastric carcinomas.
Zhao Y; Zhang T; Wang Q
Oncol Rep; 2013 Jul; 30(1):111-8. PubMed ID: 23612849
[TBL] [Abstract][Full Text] [Related]
31. The S100A4 D10V polymorphism is related to cell migration ability but not drug resistance in gastric cancer cells.
Yuan TM; Liang RY; Hsiao NW; Chuang SM
Oncol Rep; 2014 Dec; 32(6):2307-18. PubMed ID: 25310523
[TBL] [Abstract][Full Text] [Related]
32. Methylation-associated silencing of S100A4 expression in human epidermal cancers.
Li Y; Liu ZL; Zhang KL; Chen XY; Kong QY; Wu ML; Sun Y; Liu J; Li H
Exp Dermatol; 2009 Oct; 18(10):842-8. PubMed ID: 19703228
[TBL] [Abstract][Full Text] [Related]
33. Up-regulation of metastasis-promoting S100A4 (Mts-1) in rheumatoid arthritis: putative involvement in the pathogenesis of rheumatoid arthritis.
Klingelhöfer J; Senolt L; Baslund B; Nielsen GH; Skibshøj I; Pavelka K; Neidhart M; Gay S; Ambartsumian N; Hansen BS; Petersen J; Lukanidin E; Grigorian M
Arthritis Rheum; 2007 Mar; 56(3):779-89. PubMed ID: 17328050
[TBL] [Abstract][Full Text] [Related]
34. The epithelial-mesenchymal transition mediator S100A4 maintains cancer-initiating cells in head and neck cancers.
Lo JF; Yu CC; Chiou SH; Huang CY; Jan CI; Lin SC; Liu CJ; Hu WY; Yu YH
Cancer Res; 2011 Mar; 71(5):1912-23. PubMed ID: 21169409
[TBL] [Abstract][Full Text] [Related]
35. S100A4: a novel negative regulator of mineralization and osteoblast differentiation.
Duarte WR; Shibata T; Takenaga K; Takahashi E; Kubota K; Ohya K; Ishikawa I; Yamauchi M; Kasugai S
J Bone Miner Res; 2003 Mar; 18(3):493-501. PubMed ID: 12619934
[TBL] [Abstract][Full Text] [Related]
36. S100A4 accelerates tumorigenesis and invasion of human prostate cancer through the transcriptional regulation of matrix metalloproteinase 9.
Saleem M; Kweon MH; Johnson JJ; Adhami VM; Elcheva I; Khan N; Bin Hafeez B; Bhat KM; Sarfaraz S; Reagan-Shaw S; Spiegelman VS; Setaluri V; Mukhtar H
Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14825-30. PubMed ID: 16990429
[TBL] [Abstract][Full Text] [Related]
37. Oxidized S100A4 inhibits the activation of protein phosphatase 5 through S100A1 in MKN‑45 gastric carcinoma cells.
Tsuchiya M; Yamaguchi F; Shimamoto S; Fujimoto T; Tokumitsu H; Tokuda M; Kobayashi R
Int J Mol Med; 2014 Dec; 34(6):1713-9. PubMed ID: 25269953
[TBL] [Abstract][Full Text] [Related]
38. S100A4/Nonmuscle Myosin IIA/p53 Axis Contributes to Aggressive Features in Ovarian High-Grade Serous Carcinoma.
Hiruta A; Oguri Y; Yokoi A; Matsumoto T; Oda Y; Tomohiro M; Hashimura M; Jiang Z; Tochimoto M; Nakagawa M; Saegusa M
Am J Pathol; 2020 Nov; 190(11):2304-2316. PubMed ID: 32805233
[TBL] [Abstract][Full Text] [Related]
39. Binding to intracellular targets of the metastasis-inducing protein, S100A4 (p9Ka).
Chen H; Fernig DG; Rudland PS; Sparks A; Wilkinson MC; Barraclough R
Biochem Biophys Res Commun; 2001 Sep; 286(5):1212-7. PubMed ID: 11527429
[TBL] [Abstract][Full Text] [Related]
40. Subcellular distribution of S100A4 and its transcriptional regulation under hypoxic conditions in gastric cancer cell line BGC823.
Zhang R; Fu H; Chen D; Hua J; Hu Y; Sun K; Sun X
Cancer Sci; 2010 May; 101(5):1141-6. PubMed ID: 20367639
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
